化疗不良反应预警系统的构建及应用进展
|
摘要
通过对化疗不良反应预警系统构建及应用进行综述,并从化疗不良反应预警系统的概述、化疗不良反应预警系统的具体功能模块内容及护士在预警系统应用的作用方面进行介绍,总结相关的经验,以期为临床护理实践提供指导与借鉴。
引文
[1] Gronberg BH,Sundstrom S,Kaasa S,et al. Influence of comorbidity on survival,toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy[J]. Eur J Cancer,2010,46(12):2225-2234.
[2] Extermann M,Boler I,Reich RR,et al. Predicting the risk of chemotherapy toxicity in older patients. The Chemotherapy Risk Assessment Scale for high-age patients(CRASH)score[J]. Cancer,2012,118(13):3377-3386.
[3]王亚楠.新型抗肿瘤药物不良反应调查分析[D].济南:山东大学,2014.
[4]周婉,许勤,言克莉,等.消化道肿瘤化疗患者营养状况与生活质量及化疗不良反应的相关性分析[J].护理学报,2015,22(9):1-4.
[5] Asawari L,Patel P,Patel C,et al. Preventability,predictability and seriousness of adverse drug reactions amongst medicine in patients in a teaching hospital:a prospective observational study[J].Int J Pharm Chem Sci,2012,1(3):1293-1299.
[6] Gu L,Li J.The assessment and management of chemotherapyinduced nausea and vomiting among cancer patients in a chemotherapy ward:a best practice implementation project[J].JBI Database System Rev Implement Rep,2016,14(3):235-246.
[7] Davoodi S,Mohammadzadeh Z,Safdari R. Mobile phone based system opportunities to home-based managing of chemotherapy side effects[J]. Acta Inform Med,2016,24(3):193-196.
[8]赵旭,辛制高.企业风险预警管理模型研究[J].北京邮电大学学报(社会科学版),2010,10(1):93-97.
[9]徐蕊,李静,袁园,等.淋巴系恶性肿瘤患者大剂量甲氨蝶呤化疗后不良反应预测模型的研究[J].中国现代应用药学,2018,35(6):878-883.
[10] Buil-Bruna N,Lopez-Picazo JM,Martin-Algarra S,et al. Bringing model-based prediction to oncology clinical practice:a review of pharmacometrics principles and applications[J]. The Oncologist,2016,21(2):220-232.
[11] Vincent M,Dranitsaris G,Verma S,et al. The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy[J]. Support Care Cancer,2017,15(3):265-272.
[12]雷芳,朱彦,王丽霞,等.血液系统恶性肿瘤化疗后不良事件发生的危险因素分析及其风险预测模型的建立[J].实用医学杂志,2013,29(7):1073-1075.
[13]郭佳栋,张雪梅,刘影,等.基于数据挖掘技术对胃癌化疗药物不良反应关联性研究[J].药物流行病学杂志,2017,26(1):46-49.
[14] Kearney N,Mccann L,Norrie J,et al. Evaluation of a mobile phone-based,advanced symptom management system(ASyMS)in the management of chemotherapy-related toxicity[J]. Support Care Cancer,2009,17(4):437-444.
[15] Innominato PF,Komarzynski S,Mohammad-Djafari A,et al. Clinical relevance of the first domomedicine platform securing multidrug chronotherapy delivery in metastatic cancer patients at home:the in CASA European Project[J]. J Med Internet Res,2016,18(11):305-323.
[16] Cowie J,Mccann L,Maguire R,et al. Real-time management of chemotherapy toxicity using the advanced symptom management system(ASyMS)[J]. J Decis Syst,2013,22(1):43-52.
[17] Breen S,Ritchie D,Schofield P,et al. The Patient Remote Intervention and Symptom Management System(PRISMS)-a Telehealth-mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies:study protocol for a randomised controlled trial[J].Trials,2015,16(1):472-498.
[18] Egbring M,Far E,Roos M,et al. A mobile APP to stabilize daily functional activity of breast cancer patients in collaboration with the physician:a randomized controlled clinical trial[J]. J Med Internet Res,2016,18(9):238-246.
[19] Whitehead L,Seaton P. The effectiveness of self-management mobile phone and tablet apps in long-term condition management:a systematic review[J]. J Med Internet Res,2016,18(5):97-109.
[20] Ameringer S,Erickson JM,Macpherson CF,et al. Symptoms and symptom clusters identified by adolescents and young adults with cancer using a symptom heuristics App[J]. Res Nurs Health,2015,38(6):436-448.
[21] Soto-Perez-De-Celis E,Kim H,Rojo-Castillo MP,et al. A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico[J].J Geriatr Oncol,2018,9(2):145-151.
[22] Chan M,Ang E,Duong MC,et al. An online symptom care and management system to monitor and support patients receiving chemotherapy:a pilot study[J]. Int J Nurs Pract,2013,19(1):14-18.
[23] Aranda S,Jefford M,Yates P,et al. Impact of a novel nurseled prechemotherapy education intervention(ChemoEd)on patient distress,symptom burden,and treatment-related information and support needs:results from a randomised,controlled trial[J]. Ann Oncol,2012,23(1):222-231.
[24] Maguire R,Fox PA,Mccann L,et al. The eSMART study protocol:a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system(ASyMS)remote technology for patients with cancer[J]. BMJ Open,2017,7(5):15016.
[2] Extermann M,Boler I,Reich RR,et al. Predicting the risk of chemotherapy toxicity in older patients. The Chemotherapy Risk Assessment Scale for high-age patients(CRASH)score[J]. Cancer,2012,118(13):3377-3386.
[3]王亚楠.新型抗肿瘤药物不良反应调查分析[D].济南:山东大学,2014.
[4]周婉,许勤,言克莉,等.消化道肿瘤化疗患者营养状况与生活质量及化疗不良反应的相关性分析[J].护理学报,2015,22(9):1-4.
[5] Asawari L,Patel P,Patel C,et al. Preventability,predictability and seriousness of adverse drug reactions amongst medicine in patients in a teaching hospital:a prospective observational study[J].Int J Pharm Chem Sci,2012,1(3):1293-1299.
[6] Gu L,Li J.The assessment and management of chemotherapyinduced nausea and vomiting among cancer patients in a chemotherapy ward:a best practice implementation project[J].JBI Database System Rev Implement Rep,2016,14(3):235-246.
[7] Davoodi S,Mohammadzadeh Z,Safdari R. Mobile phone based system opportunities to home-based managing of chemotherapy side effects[J]. Acta Inform Med,2016,24(3):193-196.
[8]赵旭,辛制高.企业风险预警管理模型研究[J].北京邮电大学学报(社会科学版),2010,10(1):93-97.
[9]徐蕊,李静,袁园,等.淋巴系恶性肿瘤患者大剂量甲氨蝶呤化疗后不良反应预测模型的研究[J].中国现代应用药学,2018,35(6):878-883.
[10] Buil-Bruna N,Lopez-Picazo JM,Martin-Algarra S,et al. Bringing model-based prediction to oncology clinical practice:a review of pharmacometrics principles and applications[J]. The Oncologist,2016,21(2):220-232.
[11] Vincent M,Dranitsaris G,Verma S,et al. The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy[J]. Support Care Cancer,2017,15(3):265-272.
[12]雷芳,朱彦,王丽霞,等.血液系统恶性肿瘤化疗后不良事件发生的危险因素分析及其风险预测模型的建立[J].实用医学杂志,2013,29(7):1073-1075.
[13]郭佳栋,张雪梅,刘影,等.基于数据挖掘技术对胃癌化疗药物不良反应关联性研究[J].药物流行病学杂志,2017,26(1):46-49.
[14] Kearney N,Mccann L,Norrie J,et al. Evaluation of a mobile phone-based,advanced symptom management system(ASyMS)in the management of chemotherapy-related toxicity[J]. Support Care Cancer,2009,17(4):437-444.
[15] Innominato PF,Komarzynski S,Mohammad-Djafari A,et al. Clinical relevance of the first domomedicine platform securing multidrug chronotherapy delivery in metastatic cancer patients at home:the in CASA European Project[J]. J Med Internet Res,2016,18(11):305-323.
[16] Cowie J,Mccann L,Maguire R,et al. Real-time management of chemotherapy toxicity using the advanced symptom management system(ASyMS)[J]. J Decis Syst,2013,22(1):43-52.
[17] Breen S,Ritchie D,Schofield P,et al. The Patient Remote Intervention and Symptom Management System(PRISMS)-a Telehealth-mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies:study protocol for a randomised controlled trial[J].Trials,2015,16(1):472-498.
[18] Egbring M,Far E,Roos M,et al. A mobile APP to stabilize daily functional activity of breast cancer patients in collaboration with the physician:a randomized controlled clinical trial[J]. J Med Internet Res,2016,18(9):238-246.
[19] Whitehead L,Seaton P. The effectiveness of self-management mobile phone and tablet apps in long-term condition management:a systematic review[J]. J Med Internet Res,2016,18(5):97-109.
[20] Ameringer S,Erickson JM,Macpherson CF,et al. Symptoms and symptom clusters identified by adolescents and young adults with cancer using a symptom heuristics App[J]. Res Nurs Health,2015,38(6):436-448.
[21] Soto-Perez-De-Celis E,Kim H,Rojo-Castillo MP,et al. A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico[J].J Geriatr Oncol,2018,9(2):145-151.
[22] Chan M,Ang E,Duong MC,et al. An online symptom care and management system to monitor and support patients receiving chemotherapy:a pilot study[J]. Int J Nurs Pract,2013,19(1):14-18.
[23] Aranda S,Jefford M,Yates P,et al. Impact of a novel nurseled prechemotherapy education intervention(ChemoEd)on patient distress,symptom burden,and treatment-related information and support needs:results from a randomised,controlled trial[J]. Ann Oncol,2012,23(1):222-231.
[24] Maguire R,Fox PA,Mccann L,et al. The eSMART study protocol:a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system(ASyMS)remote technology for patients with cancer[J]. BMJ Open,2017,7(5):15016.